Eam Investors, LLC Mirati Therapeutics, Inc. Transaction History

Eam Investors, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$158.92 - $221.61 $1.84 Million - $2.56 Million	-11,552 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$162.05 - $240.27 $58,986 - $87,458	-364 Reduced 3.05%	11,552 $2.54 Million
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $1.35 Million - $1.99 Million	11,916 New	11,916 $1.98 Million
Q1 2020 May 13, 2020	SELL	$69.78 - $116.21 $803,935 - $1.34 Million	-11,521 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$70.76 - $128.86 $492,701 - $897,252	-6,963 Reduced 37.67%	11,521 $1.49 Million
Q3 2019 Nov 13, 2019	SELL	$77.91 - $109.6 $1.3 Million - $1.83 Million	-16,675 Reduced 47.43%	18,484 $1.44 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $271,036 - $477,058	-4,556 Reduced 11.47%	35,159 $3.62 Million
Q1 2019 May 13, 2019	BUY	$43.65 - $78.95 $1.73 Million - $3.14 Million	39,715 New	39,715 $2.91 Million
Q4 2018 Feb 13, 2019	SELL	$32.0 - $47.43 $2.21 Million - $3.27 Million	-68,981 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$47.1 - $62.7 $1.44 Million - $1.92 Million	-30,675 Reduced 30.78%	68,981 $3.25 Million
Q2 2018 Aug 03, 2018	BUY	$26.05 - $52.4 $1.01 Million - $2.02 Million	38,626 Added 63.29%	99,656 $4.91 Million
Q1 2018 May 14, 2018	BUY	$17.2 - $34.95 $450,846 - $916,109	26,212 Added 75.28%	61,030 $1.87 Million
Q4 2017 Feb 12, 2018	BUY	$12.65 - $19.0 $440,447 - $661,542	34,818	34,818 $635,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.